For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing
klimkin / Pixabay

For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing

According to a story from the Los Angeles Daily News, for children with debilitating rare illnesses like cerebral palsy, epilepsy, or muscular dystrophy, it can often take a long time…

Continue Reading For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing
A New App has Been Developed to Support the Neuroendocrine Tumour Community
JESHOOTScom / Pixabay

A New App has Been Developed to Support the Neuroendocrine Tumour Community

Novartis has teamed up with Numinous Games to develop Galaxies of Hope, an app that is designed to support the neuroendocrine tumour (NET) community. You can read the original source…

Continue Reading A New App has Been Developed to Support the Neuroendocrine Tumour Community
Study Finds that Prognosis for Systemic Sclerosis can be Predicted with this Simple Test
Free-Photos / Pixabay

Study Finds that Prognosis for Systemic Sclerosis can be Predicted with this Simple Test

According to a story from Scleroderma News, the results from a recent study suggest that the six minute walk test can accurately predict outcomes for patients with systemic sclerosis. A…

Continue Reading Study Finds that Prognosis for Systemic Sclerosis can be Predicted with this Simple Test
Artificial Intelligence Technology is Being Developed to Support the Treatment of Liver Cancer
geralt / Pixabay

Artificial Intelligence Technology is Being Developed to Support the Treatment of Liver Cancer

The organisations Guerbet and IBM Watson Health are collaborating to develop an artificial intelligence tool designed to support the diagnosis and care of liver cancer. The source article can be…

Continue Reading Artificial Intelligence Technology is Being Developed to Support the Treatment of Liver Cancer
New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis
Source: Pixabay.com

New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis

According to a story from bioportfolio.com, two companies, Ionis Pharmaceuticals, Inc., and its affiliate Akcea Pharmaceuticals, recently announced that its product inotersen (to be marketed as TEGSEDI) has gained approval…

Continue Reading New Drug Approved in the EU for Treating Hereditary Transthyretin Amyloidosis

Positive Genetic Test Results for Rare Disease Risk are not Necessarily a Cause for Alarm

According to a story from Global News, direct-to-consumer genetic tests are becoming increasingly popular. These tests can be used to learn new info about your ancient ancestors, closer relatives, and,…

Continue Reading Positive Genetic Test Results for Rare Disease Risk are not Necessarily a Cause for Alarm